Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-09-19

Clinical Trial Update: Cannabidiol Oral Solution for Treatment of Refractory Infantile Spasms [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for cannabidiol oral solution in the treatment of refractory infantile spasms; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cannabidiol Oral Solution (cannabidiol)

Snippet

Sponsor: INSYS Therapeutics Inc | Conditions: Spasms, Infantile | Phase 2 | Status: TERMINATED | Results posted: 2018-09-19